{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:56:53Z","timestamp":1785877013861,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AR060456 (FL)"],"award-info":[{"award-number":["R01 AR060456 (FL)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200431"],"award-info":[{"award-number":["81200431"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.bone.2016.01.013","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T12:09:20Z","timestamp":1452946160000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse"],"prefix":"10.1016","volume":"85","author":[{"given":"Weiwei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chih","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanxin","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2016.01.013_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrm3254","article-title":"Building strong bones: molecular regulation of the osteoblast lineage","volume":"13","author":"Long","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bone.2016.01.013_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2016.01.013_bb0015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.devcel.2005.03.016","article-title":"Wnt\/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis","volume":"8","author":"Day","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2016.01.013_bb0020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.devcel.2005.02.013","article-title":"Canonical Wnt\/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes","volume":"8","author":"Hill","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2016.01.013_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1242\/dev.01564","article-title":"Sequential roles of Hedgehog and Wnt signaling in osteoblast development","volume":"132","author":"Hu","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.bone.2016.01.013_bb0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ydbio.2011.08.020","article-title":"Lrp5 and Lrp6 redundantly control skeletal development in the mouse embryo","volume":"359","author":"Joeng","year":"2011","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bone.2016.01.013_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063323","article-title":"Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition","volume":"8","author":"Riddle","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bone.2016.01.013_bb0040","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/jbmr.1834","article-title":"Beta-catenin promotes bone formation and suppresses bone resorption in postnatal growing mice","volume":"28","author":"Chen","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0045","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2016.01.013_bb0050","doi-asserted-by":"crossref","first-page":"21162","DOI":"10.1074\/jbc.M501900200","article-title":"Essential role of beta-catenin in postnatal bone acquisition","volume":"280","author":"Holmen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.01.013_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.devcel.2006.11.003","article-title":"Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation","volume":"12","author":"Tu","year":"2007","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2016.01.013_bb0060","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","article-title":"TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth","volume":"126","author":"Inoki","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bone.2016.01.013_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004145","article-title":"WNT7B promotes bone formation in part through mTORC1","volume":"10","author":"Chen","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bone.2016.01.013_bb0070","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cmet.2013.03.017","article-title":"WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation","volume":"17","author":"Esen","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bone.2016.01.013_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jbmr.2348","article-title":"mTORC2 signaling promotes skeletal growth and bone formation in mice","volume":"30","author":"Chen","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0080","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1242\/dev.108811","article-title":"mTORC1 signaling controls mammalian skeletal growth through stimulation of protein synthesis","volume":"141","author":"Chen","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.bone.2016.01.013_bb0085","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1359\/jbmr.060810","article-title":"Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity","volume":"21","author":"Ellies","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0090","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.01.013_bb0095","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","volume":"19","author":"Poole","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2016.01.013_bb0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2016.01.013_bb0105","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0115","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1210\/en.2011-0252","article-title":"Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats","volume":"152","author":"Li","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2016.01.013_bb0120","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1002\/jbmr.182","article-title":"Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats","volume":"25","author":"Li","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0125","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jbmr.307","article-title":"Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones","volume":"26","author":"Ominsky","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.01.013_bb0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/gene.10092","article-title":"Expression of Cre recombinase in the developing mouse limb bud driven by a prxl enhancer","volume":"33","author":"Logan","year":"2002","journal-title":"Genesis"},{"key":"10.1016\/j.bone.2016.01.013_bb0140","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.devcel.2006.08.013","article-title":"Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability","volume":"11","author":"Shiota","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2016.01.013_bb0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bone.2010.09.009","article-title":"Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model","volume":"48","author":"Tian","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bone.2016.01.013_bb0150","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcb.1202","article-title":"Tumor necrosis factor-alpha mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism","volume":"83","author":"Zou","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bone.2016.01.013_bb0160","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1359\/jbmr.2000.15.8.1477","article-title":"Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts","volume":"15","author":"Takeshita","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1083\/jcb.201410123","article-title":"Absence of Dap12 and the alphavbeta3 integrin causes severe osteopetrosis","volume":"208","author":"Zou","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2016.01.013_bb0170","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1074\/jbc.M400524200","article-title":"Sclerostin inhibition of Wnt-3a-induced C3H10T1\/2 cell differentiation is indirect and mediated by bone morphogenetic proteins","volume":"280","author":"Winkler","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2016.01.013_bb0175","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1073\/pnas.0408742102","article-title":"Regulation of osteoblastogenesis and bone mass by Wnt10b","volume":"102","author":"Bennett","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bone.2016.01.013_bb0180","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/jbmr.118","article-title":"Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells","volume":"25","author":"Stevens","year":"2010","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/jmedgenet-2013-101567","article-title":"Mutations in WNT1 are a cause of osteogenesis imperfecta","volume":"50","author":"Fahiminiya","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bone.2016.01.013_bb0190","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ajhg.2013.02.010","article-title":"Mutations in WNT1 cause different forms of bone fragility","volume":"92","author":"Keupp","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2016.01.013_bb0195","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1215458","article-title":"WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta","volume":"368","author":"Laine","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2016.01.013_bb0200","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ajhg.2013.02.009","article-title":"WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta","volume":"92","author":"Pyott","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2016.01.013_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004145","article-title":"WNT7B promotes bone formation in part through mTORC1","volume":"10","author":"Chen","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bone.2016.01.013_bb0210","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/jbmr.1834","article-title":"Beta-catenin promotes bone formation and suppresses bone resorption in postnatal growing mice","volume":"28","author":"Chen","year":"2013","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."},{"key":"10.1016\/j.bone.2016.01.013_bb0215","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/jbmr.1694","article-title":"Loss of wnt\/beta-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytes","volume":"27","author":"Song","year":"2012","journal-title":"J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328216000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T15:14:15Z","timestamp":1567523655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328216000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":43,"alternative-id":["S8756328216000144"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2016.01.013","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rictor is required for optimal bone accrual in response to anti-sclerostin therapy in the mouse","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2016.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}